Electrospun nanofibers loaded with quercetin promote the recovery of focal entrapment neuropathy in a rat model of streptozotocin-induced diabetes

BioMed Research International

Volumn 2017, Issue , 2017, Pages

  Thipkaew, Chonlathip ^a,b   Wattanathorn, Jintanaporn ^a,b   Muchimapura, Supaporn ^a,b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; NANOFIBER; QUERCETIN; STREPTOZOCIN; ZEIN; MITOGEN ACTIVATED PROTEIN KINASE; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRUSH TRAUMA; DRUG MECHANISM; ELECTROSPINNING; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXPERIMENTAL SCIATIC NERVE INJURY; HISTOLOGY; MALE; NERVE CONDUCTION VELOCITY; NONHUMAN; OXIDATIVE STRESS; RAT; RAT MODEL; STREPTOZOTOCIN-INDUCED DIABETIC NEUROPATHY; WISTAR RAT; X RAY DIFFRACTION; ANIMAL; AXON; CHEMISTRY; CONVALESCENCE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; INFRARED SPECTROSCOPY; METABOLISM; NANOTECHNOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PROCEDURES; SCIATIC NERVE; ULTRASTRUCTURE;

ANIMALS; AXONS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MALE; NANOFIBERS; NANOTECHNOLOGY; OXIDATIVE STRESS; PHOSPHORYLATION; POLYMERS; QUERCETIN; RATS, WISTAR; RECOVERY OF FUNCTION; SCIATIC NERVE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION; ZEIN;

EID: 85013230933     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2017/2017493     Document Type: Article

References (28)

1. A. L. Dellon, "A cause for optimism in diabetic neuropathy," Annals of Plastic Surgery, Vol. 20, no. 2, pp. 103-105, 1988.
2. J. Jakobsen, "Peripheral nerves in early experimental diabetes: expansion of the endoneurial space as a cause of increased water content," Diabetologia, Vol. 14, no. 2, pp. 113-119, 1978.
3. K. H. Gabbay, N. Spack, S. Loo, H. J. Hirsch, and A. A. Ackil, "Aldose reductase inhibition: studies with alrestatin," Metabolism, Vol. 28, no. 4, pp. 471-476, 1979.
4. B. E. Layton, A. M. Sastry, H. Wang et al., "Differences between collagen morphologies, properties and distribution in diabetic and normal biobreeding and Sprague-Dawley rat sciatic nerves," Journal of Biomechanics, Vol. 37, no. 6, pp. 879-888, 2004.
5. R.-J. Chen, C.-C. K. Lin, and M.-S. Ju, "In situ biomechanical properties of normal and diabetic nerves: an efficient quasilinear viscoelastic approach," Journal of Biomechanics, Vol. 43, no. 6, pp. 1118-1124, 2010.
6. C. Lanza, S. Raimondo, L. Vergani et al., "Expression of antioxidant molecules after peripheral nerve injury and regeneration," Journal of Neuroscience Research, Vol. 90, no. 4, pp. 842-848, 2012.
7. D. A. Greene, M. J. Stevens, I. Obrosova, and E. L. Feldman, "Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy," European Journal of Pharmacology, Vol. 375, no. 1-3, pp. 217-223, 1999.
8. N. E. Cameron, M. A. Cotter, V. Archibald, K. C. Dines, and E. K. Maxfield, "Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats," Diabetologia, Vol. 37, no. 5, pp. 449-459, 1994.
9. A. A. Gerritsen, H. C. de Vet, R. J. Scholten, F. W. Bertelsmann, M. C. de Krom, and L. M. Bouter, "Splinting vs surgery in the treatment of carpal tunnel syndrome: a randomized controlled trial," Japan Automobile Manufacturers Association, Vol. 288, pp. 1245-1251, 2002.
10. M. Zhang, S. G. Swarts, L. Yin et al., "Antioxidant properties of quercetin," Advances in experimental medicine and biology, Vol. 701, pp. 283-289, 2011.
11. L. Biasutto, A. Mattarei, N. Sassi et al., "Improving the efficacy of plant polyphenols," Anti-Cancer Agents in Medicinal Chemistry, Vol. 14, no. 10, pp. 1332-1342, 2014.
12. M. Comalada, D. Camuesco, S. Sierra et al., "In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-κB pathway," European Journal of Immunology, Vol. 35, no. 2, pp. 584-592, 2005.
13. R. Kleemann, L. Verschuren, M. Morrison et al., "Antiinflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models," Atherosclerosis, Vol. 218, no. 1, pp. 44-52, 2011.
14. M. Vessal, M. Hemmati, and M. Vasei, "Antidiabetic effects of quercetin in streptozocin-induced diabetic rats," Comparative Biochemistry and Physiology - C Toxicology and Pharmacology, Vol. 135, no. 3, pp. 357-364, 2003.
15. F. Perez-Vizcaino, J. Duarte, R. Jimenez, C. Santos-Buelga, and A. Osuna, "Antihypertensive effects of the flavonoid quercetin," Pharmacological Reports, Vol. 61, no. 1, pp. 67-75, 2009.
16. N. Haleagrahara, C. J. Siew, N. K. Mitra, and M. Kumari, "Neuroprotective effect of bioflavonoid quercetin in 6-hydroxydopamine-induced oxidative stress biomarkers in the rat striatum," Neuroscience Letters, Vol. 500, no. 2, pp. 139-143, 2011.
17. A. D. Kandhare, K. S. Raygude, V. Shiva Kumar et al., "Ameliorative effects quercetin against impaired motor nerve function, inflammatory mediators and apoptosis in neonatal streptozotocin-induced diabetic neuropathy in rats," Biomedicine & Aging Pathology, Vol. 2, no. 4, pp. 173-186, 2012.
18. P. Pangphukiew, J. Wattanathorn, S. Muchimapura, and W. Thkham-mee, "Quercetin-loaded zein based nanofiber patch: a novel cognitive enhancer," International Journal of Pharmacy and Biomedical Sciences, Vol. 3, no. 3, pp. 103-108, 2012.
19. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, "Protein measurement with the folin phenol reagent," The Journal of Biological Chemistry, Vol. 193, no. 1, pp. 265-275, 1951.
20. H. Ohkawa, N. Ohishi, and K. Yagi, "Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction," Analytical Biochemistry, Vol. 95, no. 2, pp. 351-358, 1979.
21. P. Taepaiboon, U. Rungsardthong, and P. Supaphol, "Vitamin-loaded electrospun cellulose acetate nanofiber mats as transdermal and dermal therapeutic agents of vitamin A acid and vitamin E," European Journal of Pharmaceutics and Biopharmaceutics, Vol. 67, no. 2, pp. 387-397, 2007.
22. X.-Y. Li, C.-J. Shi, D.-G. Yu, Y.-Z. Liao, and X. Wang, "Electrospun quercetin-loaded zein nanoribbons," Bio-Medical Materials and Engineering, Vol. 24, no. 6, pp. 2015-2023, 2014.
23. T. M. Reeves, L. L. Phillips, and J. T. Povlishock, "Myelinated and unmyelinated axons of the corpus callosum differ in vulnerability and functional recovery following traumatic brain injury," Experimental Neurology, Vol. 196, no. 1, pp. 126-137, 2005.
24. J. Hofmeijer, H. Franssen, L. J. van Schelven, and M. J. A. M. van Putten, "Why are sensory axons more vulnerable for ischemia than motor axons?" PLoS ONE, Vol. 8, no. 6, Article ID e67113, 2013.
25. S. Rotshenker, "Wallerian degeneration: the innate-immune response to traumatic nerve injury," Journal of Neuroinflammation, Vol. 8, article no. 109, 2011.
26. M. Senoglu, V. Nacitarhan, E. B. Kurutas et al., "Intraperitoneal Alpha-Lipoic Acid to prevent neural damage after crush injury to the rat sciatic nerve," Journal of Brachial Plexus and Peripheral Nerve Injury, Vol. 4, no. 1, article 22, 2009.
27. S. L. Fyffe-Maricich, A. Schott, M. Karl, J. Krasno, and R. H. Miller, "Signaling through ERK1/2 controls myelin thickness during myelin repair in the adult central nervous system," The Journal of Neuroscience, Vol. 33, no. 47, pp. 18402-18408, 2013.
28. J. Y. Sheu, D. J. Kulhanek, and F. P. Eckenstein, "Differential patterns of ERK and STAT3 phosphorylation after sciatic nerve transection in the rat," Experimental Neurology, Vol. 166, no. 2, pp. 392-402, 2000.